Natural Acute Graft vs. Host Disease Treatment in Leukemia and Lymphoma Patients: Molecular Hydrogen Therapy
DISCLAIMER: Always consult a doctor before undergoing treatment of any kind.
Leukemia and lymphoma are usually treated in conventional medicine using chemotherapy and radiation. These treatments often lead to the death of stem cells. As a result, many leukemia and lymphoma patients must receive Allogeneic Haematopoietic Stem Cell Transplantation as part of their conventional treatment protocol. But allogeneic hematopoietic stem cell transplants often cause serious, life-threatening complications. Scientists, however, have noted that the use of molecular hydrogen via inhalation or in the form of high concentration molecular hydrogen drinking water can diminish these effects in part by reducing cytokine levels including:
Acute Graft vs. Host Disease Cure
Typically, if a leukemia patient develops acute graft vs. host disease, the doctor prescribes high-dose steroids and the mortality rate following the development of the disease plus the steroid treatment is very high.
In contrast, molecular hydrogen is therapeutic as a cure for acute graft vs. host disease by downregulating cytokine production. Drinking water that contains high concentrations of molecular hydrogen is non-toxic at any pressure and it has the ability to penetrate cellular membranes. It can diffuse into cytosol, and even reach the mitochondria of cells to re-energize them. Molecular hydrogen, as a tiny molecule, also has the ability to enter the nucleus of human cells to protect DNA from damage by free radicals.
High concentrations of molecular hydrogen can be administered in drinking water or through the air at 4.6% concentration. It functions as:
- An antioxidant
- An antiapoptotic agent that can protect cells from death
- An anti-inflammatory agent
Patients can drink high concentration molecular hydrogen water or they can nebulize it. This treatment does not interfere with other conventional medicine treatments the patient may be undergoing.
Other Important Links:
Quian, L., and Shen, J. (2013). Hydrogen therapy may be an effective and specific novel treatment for Acute Graft versus Host Disease (GVHD). Retrieved March 2, 2022 from https://onlinelibrary.wiley.com/doi/10.1111/jcmm.12081